Huai Heng Loh

Huai Heng Loh

Auto-generated profile, based on publicly available information

Huai Heng Loh

Department of Medicine, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2019 in BMC Psychiatry
Verified
Journal Article
Open access
PDF file
HLHuai Heng Loh
Huai Heng Loh
LLLee-Ling Lim
Lee-Ling Lim
YYYee Hway Ann @ Anne Yee
Yee Hway Ann @ Anne Yee
HLHuai Seng Loh
Huai Seng Loh
Although depression is associated with changes in the hypothalamic-pituitary-thyroid axis, its relationship with subclinical hypothyroidism (SCH) is controversial. To date, there is a lack of data on the improvement of depressive symptoms with levothyroxine therapy among individuals with coexistent SCH. We conducted a meta-analysis to evaluate the association between SCH and depression including 1) the prevalence of depression in SCH (with a sub-analysis of the geriatric cohort), 2) thyroid stimulating hormone (TSH) level among patients with depression and 3) the effect of levothyroxine therapy among patients with SCH and coexistent depression. In a pooled analysis of 12,315 individuals, those with SCH had higher risk of depression than euthyroid controls (relative risk 2.35, 95% confidence intervals [CI], 1.84 to 3.02; p < 0.001). Geriatric cohort with SCH had a 1.7-fold higher risk of depression compared with healthy controls (odds ratio 1.72, CI, 1.10 to 2.70; p = 0.020). There was no difference in the mean TSH level between individuals with depression and healthy controls (2.30 ± 1.18 vs. 2.13 ± 0.72 mIU/L, p = 0.513). In individuals with SCH and coexistent depression, levothyroxine therapy was neither associated with improvement in the Beck Depression Inventory scoring (pooled d + = − 1.05, CI -2.72 to 0.61; p = 0.215) nor Hamilton Depression Rating Scale (pooled d + = − 2.38, CI -4.86 to 0.10; p = 0.060). SCH has a negative impact on depression. Early and routine screening of depression is essential to prevent morbidity and mortality. However, the use of levothyroxine among patients with SCH and coexistent depression needs to be individualized.

23 April 2021 in Diabetes/Metabolism Research and Reviews
Verified
Journal Article
Open access
PDF file
HLHuai Heng Loh
Huai Heng Loh
BFBenedict Francis
Benedict Francis
LLLee-Ling Lim
Lee-Ling Lim
QLQuan Hziung Lim
Quan Hziung Lim
AYAnne Yee
Anne Yee
HLHuai Seng Loh
Huai Seng Loh
Aims: We aimed to examine if bariatric surgery was associated with a reduction in the prevalence of depressive and anxiety symptoms among people with obesity.Materials and Methods: We pooled data from 49 studies involving 11,255 people with obesity who underwent bariatric surgery. The study outcomes were the prevalence of depressive and anxiety symptoms among these patients pre‐ and post‐surgery.Results: There was a significant reduction in body mass index (BMI) post‐operatively (pooled d+: −13.3 kg/m2 [95% confidence interval [CI] 15.19, −11.47], p < 0.001). The pooled proportion of patients with anxiety symptoms reduced from 24.5% pre‐operatively to 16.9% post‐operatively, with an odds ratio (OR) of 0.58 (95% CI 0.51, 0.67, p < 0.001). The reduction remained significant in women aged ≥40 years and irrespective of post‐operative BMI. There were significant reductions in Hospital Anxiety and Depression Score (HADS) (anxiety component) by 0.64 (pooled d+: −0.64 [95% CI −1.06, −0.22], p = 0.003) and Generalized Anxiety Disorder Assessment‐7 score by 0.54 (pooled d+: −0.54 [95% CI −0.64, −0.44], p < 0.001). The pooled proportion of depressive symptoms reduced from 34.7% pre‐operatively to 20.4% post‐operatively, with an OR of 0.49 (95% CI 0.37, 0.65, p < 0.001). The reduction remained significant irrespective of patient's age and post‐operative BMI. There were also significant reductions in HADS score (depressive component) (pooled d+: −1.34 [95% CI −1.93, −0.76], p < 0.001), Beck’s Depression Inventory score (pooled d+: −1.04 [95% CI −1.46, −0.63], p < 0.001) and Patient Health Questionnaire‐9 score (pooled d+: −1.11 [95% CI −1.21, −1.01], p < 0.001).Conclusion: Bariatric surgery was associated with significant reduction in the prevalence and severity of depressive and anxiety symptoms among people with obesity.

27 May 2020 in Hormones
Verified
Journal Article
Closed access
PDF file
YYYee Hway Ann @ Anne Yee
Yee Hway Ann @ Anne Yee
HLHuai Seng Loh
Huai Seng Loh
Sharmilla KanagasundramSharmilla Kanagasundram
Sharmilla Kanagasundram
BFBenedict Francis
Benedict Francis
LLLee-Ling Lim
Lee-Ling Lim

14 September 2022 in Journal of Sleep Research
Verified
Journal Article
Open access
HLHuai Heng Loh
Huai Heng Loh
QLQuan Hziung Lim
Quan Hziung Lim
CCChee Shee Chai
Chee Shee Chai
SGSiew Li Goh
Siew Li Goh
LLLee-Ling Lim
Lee-Ling Lim
NSNorlela Sukor
Norlela Sukor
Summary: Obstructive sleep apnea is a chronic, sleep‐related breathing disorder, which is an independent risk factor for cardiovascular disease. The renin–angiotensin–aldosterone system regulates salt and water homeostasis, blood pressure, and cardiovascular remodelling. Elevated aldosterone levels are associated with excess morbidity and mortality. We aimed to analyse the influence and implications of renin–angiotensin–aldosterone system derangement in individuals with and without obstructive sleep apnea. We pooled data from 20 relevant studies involving 2828 participants (1554 with obstructive sleep apnea, 1274 without obstructive sleep apnea). The study outcomes were the levels of renin–angiotensin–aldosterone system hormones, blood pressure and heart rate. Patients with obstructive sleep apnea had higher levels of plasma renin activity (pooled wmd+ 0.25 [95% confidence interval 0.04–0.46], p = 0.0219), plasma aldosterone (pooled wmd+ 30.79 [95% confidence interval 1.05–60.53], p = 0.0424), angiotensin II (pooled wmd+ 5.19 [95% confidence interval 3.11–7.27], p < 0.001), systolic (pooled wmd+ 5.87 [95% confidence interval 1.42–10.32], p = 0.0098) and diastolic (pooled wmd+ 3.40 [95% confidence interval 0.86–5.94], p = 0.0086) blood pressure, and heart rate (pooled wmd+ 3.83 [95% confidence interval 1.57–6.01], p = 0.0009) compared with those without obstructive sleep apnea. The elevation remained significant (except for renin levels) when studies involving patients with resistant hypertension were removed. Sub‐group analysis demonstrated that levels of angiotensin II were significantly higher only among the Asian population with obstructive sleep apnea compared with those without obstructive sleep apnea. Body mass index accounted for less than 10% of the between‐study variance in elevation of the renin–angiotensin–aldosterone system parameters. Patients with obstructive sleep apnea have higher levels of renin–angiotensin–aldosterone system hormones, blood pressure and heart rate compared with those without obstructive sleep apnea, which remains significant even among patients without resistant hypertension.

14 September 2023 in Hormones
Verified
Journal Article
Closed access
PDF file
HLHuai Heng Loh
Huai Heng Loh
QLQuan Hziung Lim
Quan Hziung Lim
WKWaye Hann Kang
Waye Hann Kang
YYYee Hway Ann @ Anne Yee
Yee Hway Ann @ Anne Yee
MYMei Ching Yong
Mei Ching Yong
NSNorlela Sukor
Norlela Sukor

2 December 2017 in BMC Psychiatry
Verified
Journal Article
Open access
PDF file
YYYee Hway Ann @ Anne Yee
Yee Hway Ann @ Anne Yee
BNBoon Seng Ng
Boon Seng Ng
HHHelenna Maria Hisham Hashim
Helenna Maria Hisham Hashim
MAHMOUD DANAEEMAHMOUD DANAEE
MAHMOUD DANAEE
HLHuai Heng Loh
Huai Heng Loh
This study evaluates the psychometric properties of the Malay version of the Brief Psychiatric Rating Scale (BPRS-M) among patients with schizophrenia in a psychiatric outpatient clinic. Ninety-nine schizophrenia outpatients were administered the Malay version of the Brief Psychiatric Rating Scale (BPRS-M), Malay version of Positive and Negative Syndrome Scale (PANSS), Malay version of Calgary Depression Scale for Schizophrenia (CDSS) and Malay version of World Health Organization Quality of Life – Brief Version (WHOQOL-BREF). An exploratory factor analysis (EFA) of BPRS-M produced a seven-factor solution which accounted for 71.4% of the total variance. It exhibited fair internal consistency (Cronbach’s alpha coefficient of 0.75). “Positive symptoms” and “Resistance” factors had association with unemployment and number of antipsychotics, positively correlated with PANSS but negatively correlated with WHOQOL-BREF. “Mood disturbance” factor correlated with lifetime history of suicide attempts, Malay version of CDSS and WHOQOL-BREF (psychological). Both “Negative symptoms” and “Activation” factors were associated with male, lower education, unemployment and positively correlated with Malay version of PANSS but negatively correlated with WHOQOL-BREF. The BPRS-M demonstrated promising psychometric properties in terms of dimensionality, reliability, and validity that generally justifies its use in routine clinical practice in Malaysia.